Emerging cellular targets for influenza antiviral agents

Area of Science:

• Virology
• Drug Discovery
• Molecular Biology

Background:

• Influenza A virus (IAV) causes substantial global morbidity and mortality.
• Existing antiviral treatments are becoming less effective due to increasing viral drug resistance.
• Understanding IAV replication is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To review current knowledge on IAV replication.
• To identify emerging cellular drug targets that can overcome viral drug resistance.
• To explore the potential of existing human-tested compounds for IAV treatment.

Main Methods:

• Literature review of IAV replication mechanisms.
• Identification and analysis of cellular pathways targeted by IAV.
• Evaluation of existing drugs targeting identified cellular pathways.

Main Results:

• IAV replication relies on specific host cell machinery.
• Several cellular targets, including heat shock protein 90, proteasome, importin α5, and protein kinase C, are key to IAV replication.
• Compounds targeting these cellular proteins have undergone human safety testing.

Conclusions:

• Emerging cellular drug targets offer a promising strategy to combat IAV drug resistance.
• Existing compounds targeting host cell factors may be repurposed for IAV treatment.
• Further evaluation in clinical settings is necessary to validate these compounds for IAV infections.